Pavadi Capital’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$3.51M Sell
46,433
-46,234
-50% -$2.93M 4.32% 13
2023
Q3
$6.11M Sell
92,667
-10,613
-10% -$793K 7.95% 2
2023
Q2
$8.4M Sell
103,280
-17,152
-14% -$1.22M 9.81% 1
2023
Q1
$7.16M Buy
120,432
+18,705
+18% +$1.04M 7.81% 4
2022
Q4
$4.96M Buy
101,727
+15,191
+18% +$702K 4.68% 14
2022
Q3
$4.46M Sell
86,536
-8,345
-9% -$495K 4.27% 9
2022
Q2
$4.99M Buy
94,881
+15,111
+19% +$1.05M 4.52% 10
2022
Q1
$6.86M Sell
79,770
-7,382
-8% -$606K 6.04% 3
2021
Q4
$7.12M Buy
+87,152
New +$6.37M 5.4% 6

Other funds holding THC

Pavadi Capital's THC Position: Q4 2023 in Review

Pavadi Capital reduced its Tenet Healthcare (THC) stake by 50% in Q4 2023, selling an estimated $2.93M and leaving 46,433 shares worth $3.51M. The position accounts for 4.32% of the portfolio, ranked #13.

Pavadi Capital first reported a position in THC in Q4 2021 and has held it in 9 quarters since. The position peaked at $8.4M in Q2 2023. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.

  • Pavadi Capital held 46,433 shares of Tenet Healthcare worth $3.51M as of Q4 2023.
  • Pavadi Capital sold 46,234 Tenet Healthcare shares in Q4 2023, an estimated $2.93M.
  • Tenet Healthcare made up 4.32% of Pavadi Capital's portfolio in Q4 2023, its #13 holding.
  • Pavadi Capital first reported a position in Tenet Healthcare in Q4 2021 and has held it in 9 quarters since.
  • Pavadi Capital's Tenet Healthcare position peaked at $8.4M in Q2 2023.
  • 425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.

Based on Pavadi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.